Bridgecreek Investment Management, LLC Edwards Lifesciences Corp Transaction History

Bridgecreek Investment Management, LLC

$518 Million
Q4 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $14.7 Million - $18.6 Million	-144,610 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$106.37 - $130.68 $7,977 - $9,801	-75 Reduced 0.05%	144,610 $18.7 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $62,260 - $74,263	-605 Reduced 0.42%	144,685 $16.4 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $1.17 Million - $1.46 Million	-13,965 Reduced 8.77%	145,290 $15 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $110,938 - $127,844	-1,410 Reduced 0.88%	159,255 $13.3 Million
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $96,781 - $123,160	1,350 Added 0.85%	160,665 $14.7 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $8,062 - $10,492	120 Added 0.08%	159,315 $12.7 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $6.11 Million - $8.17 Million	106,170 Added 200.23%	159,195 $11 Million
Q1 2020 May 01, 2020	BUY	$52.41 - $81.0 $69,443 - $107,325	1,325 Added 2.56%	53,025 $10 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $5,377 - $6,156	75 Added 0.15%	51,700 $12.1 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $23,389 - $28,663	380 Added 0.74%	51,625 $11.4 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $8,639 - $9,983	155 Added 0.3%	51,245 $9.47 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $42,382 - $56,684	885 Added 1.76%	51,090 $9.78 Million
Q4 2018 Feb 12, 2019	SELL	$46.41 - $56.94 $22,972 - $28,185	-495 Reduced 0.98%	50,205 $7.69 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $9,597 - $12,186	210 Added 0.42%	50,700 $8.83 Million
Q2 2018 Aug 03, 2018	BUY	$42.45 - $51.3 $21,225 - $25,650	500 Added 1.0%	50,490 $7.35 Million
Q1 2018 Apr 25, 2018	BUY	$37.19 - $47.45 $38,119 - $48,636	1,025 Added 2.09%	49,990 $6.98 Million
Q4 2017 Feb 06, 2018	BUY	$33.79 - $39.39 $134,991 - $157,363	3,995 Added 8.88%	48,965 $5.52 Million
Q3 2017 Nov 06, 2017	BUY	$36.29 - $38.83 $97,075 - $103,870	2,675 Added 6.32%	44,970 $4.92 Million
Q2 2017 Aug 14, 2017	BUY	N/A	42,295	42,295 $5 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgecreek Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgecreek Investment Management, LLC with notifications on news.

Account